Exothera
Michael Lambin is a seasoned professional in the field of biochemistry and quality control, currently serving as Senior Technical Lead and Technology and Manufacturing Lead at Exothera Nucleic Acids since April 2023. Previously, Michael held various roles at GSK from January 2011 to May 2022, culminating in the position of Head of QC Continuous Method Validation, where accountability included ensuring the validated status of QC analytical methods for vaccines in compliance with international guidelines. Michael successfully built and led a team that increased compliance with the validation master plan, achieving over 98%. Earlier roles included QC Manager and Global QC Manager, focusing on biochemical assays and providing scientific expertise to global quality teams. Academic credentials include a Ph.D. in Biochemistry, Molecular and Cellular Biology, from Université catholique de Louvain, accompanied by additional degrees in biological sciences and specialization in biochemistry.
This person is not in any teams
This person is not in any offices
Exothera
Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing. Company number: 0744643660 VAT: BE0744643660